{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:33:33Z","timestamp":1793316813008,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005278","name":"Universidad de Antioquia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006702","name":"Universidade do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008331","name":"Universidade Federal do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014131","name":"McGill University Health Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015075","name":"Kagawa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003402","name":"Fundaci\u00f3n Valle del Lili","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007870","name":"Department of Obstetrics and Gynecology, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021510","name":"Department of Haematology, Christian Medical College, Vellore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008183","name":"Central Manchester University Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012324","name":"University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016286","name":"Urmia University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008786","name":"Universidad Nacional Mayor de San Marcos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010600","name":"Tays","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010779","name":"Centre hospitalier universitaire Sainte-Justine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012446","name":"Akershus Universitetssykehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009232","name":"Debreceni Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.autrev.2022.103055","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T12:16:34Z","timestamp":1643026594000},"page":"103055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the \u201cCAPS Registry\u201d"],"prefix":"10.1016","volume":"21","author":[{"given":"Brenda","family":"L\u00f3pez-Benjume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Carmen","family":"Amigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103055_bb0005","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103055_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.berh.2016.07.004","article-title":"Catastrophic antiphospholipid syndrome: the current management approach","volume":"30","author":"Rodriguez-Pint\u00f3","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103055_bb0015","first-page":"346","article-title":"The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus","volume":"34","author":"Bayraktar","year":"2007","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2022.103055_bb0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.autrev.2011.04.031","article-title":"Management of refractory cases of catastrophic antiphospholipid syndrome","volume":"10","author":"Espinosa","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103055_bb0025","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103055_bb0030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.autrev.2016.07.020","article-title":"Complement and thrombosis in the antiphospholipid syndrome","volume":"15","author":"Oku","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2022.103055_bb0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.autrev.2019.03.015","article-title":"Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab","volume":"18","author":"Ruffatti","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103055_bb0040","first-page":"1","article-title":"EMEA fact sheet 2007","author":"Agency EM","year":"2007","journal-title":"Eculizumab."},{"issue":"18","key":"10.1016\/j.autrev.2022.103055_bb0045","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMc0910965","article-title":"Eculizumab and renal transplantation in a patient with CAPS","volume":"362","author":"Lonze","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.autrev.2022.103055_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.autrev.2022.103055_bb0055","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2022.103055_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14Th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev [Internet]"},{"issue":"8","key":"10.1016\/j.autrev.2022.103055_bb0065","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.34440","article-title":"Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab","volume":"64","author":"Shapira","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"26","key":"10.1016\/j.autrev.2022.103055_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000143","article-title":"Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report","volume":"93","author":"Kronbichler","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103055_bb0075","first-page":"704371","article-title":"36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature","volume":"2014","author":"Strakhan","year":"2014","journal-title":"Case Rep Hematol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103055_bb0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/eye.2014.39","article-title":"Antiphospholipid antibody-associated choroidopathy","volume":"28","author":"Silva","year":"2014","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.autrev.2022.103055_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/RHU.0000000000000290","article-title":"Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome","volume":"21","author":"Zikos","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103055_bb0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/rheumatology\/kev371","article-title":"A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor","volume":"55","author":"Wig","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2022.103055_bb0095","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/rheumatology\/kew040","article-title":"Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome","volume":"55","author":"Barratt-Due","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"22","key":"10.1016\/j.autrev.2022.103055_bb0100","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood.V128.22.2603.2603","article-title":"Management of catastrophic antiphosphopholipid syndrome with eculizumab","volume":"128","author":"Chitalia","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.autrev.2022.103055_bb0105","doi-asserted-by":"crossref","first-page":"A278","DOI":"10.1016\/j.chest.2017.08.304","article-title":"Diagnostic dilemma: multiorgan failure due to catastrophic antiphospholipid syndrome in a young woman with six healthy children","volume":"152","author":"Ho","year":"2017","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.autrev.2022.103055_bb0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/rheumatology\/key228","article-title":"Eculizumab for catastrophic antiphospholipid syndrome-a case report and literature review","volume":"57","author":"Guillot","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"40","key":"10.1016\/j.autrev.2022.103055_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012584","article-title":"Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: a case report","volume":"97","author":"Rovere-Querini","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2022.103055_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10238-019-00565-8","article-title":"Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature","volume":"19","author":"Tinti","year":"2019","journal-title":"Clin Exp Med"},{"issue":"5","key":"10.1016\/j.autrev.2022.103055_bb0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.autrev.2019.03.015","article-title":"Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab","volume":"18","author":"Ruffatti","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2022.103055_bb0130","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/0961203319871099","article-title":"Systemic lupus and catastrophic antiphospholipid syndrome manifesting as cardiogenic shock","volume":"28","author":"Schultz","year":"2019","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.autrev.2022.103055_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0961203320917460","article-title":"Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature","volume":"29","author":"Skoczynska","year":"2020","journal-title":"Lupus"},{"issue":"21","key":"10.1016\/j.autrev.2022.103055_bb0140","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1182\/blood.2020007499","article-title":"Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab","volume":"136","author":"Yelnik","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2022.103055_bb0145","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/bjh.17783","article-title":"Early use of eculizumab for catastrophic antiphospholipid syndrome","volume":"196","author":"Faguer","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2022.103055_bb0150","first-page":"455","article-title":"Antiphospholipid antibodies and complement activation in patients with cerebral ischemia","volume":"10","author":"Davis","year":"1992","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103055_bb0155","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.kint.2019.05.008","article-title":"Eculizumab deposits in vessel walls in thrombotic microangiopathy","volume":"96","author":"Cassol","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.autrev.2022.103055_bb0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","article-title":"Invasive meningoccocal disease in patients with complement deficiencies: a case series (2008-2017)","volume":"19","author":"Ladhani","year":"2019","journal-title":"BMC Infect Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:25:46Z","timestamp":1761600346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1568997222000258"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103055","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the \u201cCAPS Registry\u201d","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103055"}}